CRESCENT BIOPHARMA INC (CBIO:NASDAQ)
$18.17 -0.93 (-4.8691%)
Analysed CRESCENT BIOPHARMA INC (CBIO:NASDAQ) News Sources
Crescent Biopharma Announces Grants of Inducement Awards
27-03-2026
yahoo.com
Crescent Biopharma: Q4 Earnings Snapshot
26-02-2026
yahoo.com
Crescent Biopharma Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
26-02-2026
yahoo.com
Crescent Biopharma to Present at March Investor Conferences
23-02-2026
yahoo.com
Crescent Biopharma Announces First Patient Dosed in ASCEND Phase 1/2 Clinical Trial of CR-001 for the Treatment of Advanced Solid Tumors
18-02-2026
yahoo.com
Crescent Biopharma to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026
05-02-2026
yahoo.com
Kelun-Biotech Receives Investigational New Drug Approval for ITGB6-Targeted ADC SKB105 from the NMPA
05-01-2026
yahoo.com
Crescent Biopharma Announces Regulatory Clearances of IND Applications for CR-001, a PD-1 x VEGF Bispecific Antibody and CR-003, an ITGB6-targeted ADC, for the Treatment of Solid Tumors
05-01-2026
yahoo.com
Huge Insider Buying in MGM and Salesforce
12-12-2025
247wallst.com
Crescent and Kelun-Biotech swap cancer asset rights in double deal
05-12-2025
pharmaceutical-technology.com
What is the current price of CRESCENT BIOPHARMA INC (CBIO:NASDAQ)?
The current price of CRESCENT BIOPHARMA INC (CBIO:NASDAQ) is $18.17.
CRESCENT BIOPHARMA INC (CBIO:NASDAQ) absolute price change since previous trading day?
The absolute price change of CRESCENT BIOPHARMA INC (CBIO:NASDAQ) since the previous trading day is $-0.93.
CRESCENT BIOPHARMA INC (CBIO:NASDAQ) percentage price change since previous trading day?
The percentage price change of CRESCENT BIOPHARMA INC (CBIO:NASDAQ) since the previous trading day is -4.8691%.
What is the most recent average sentiment score for CRESCENT BIOPHARMA INC (CBIO:NASDAQ)?
The most recent average sentiment score for CRESCENT BIOPHARMA INC (CBIO:NASDAQ) is 63 out of 100.
What is the most recent average sentiment for CRESCENT BIOPHARMA INC (CBIO:NASDAQ)?
The most recent sentiment for CRESCENT BIOPHARMA INC (CBIO:NASDAQ) is .
SEC-8K** Filing Available For CRESCENT BIOPHARMA INC (CBIO:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.